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Synthesis and NMR characterization of dendrimers based on  
2, 2-bis-(hydroxymethyl)-propanoic acid (bis-HMPA) 
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General Procedure for protecting Amino Acids 15a-f:  
A solution of the amino acid and base in the proper solvent system was cooled to 0 °C and treated 
with di-tert-butylcarbonate (1.1 equiv./amino group). The mixture was left overnight at r.t. under magnetic 
stirring. The disappearance of amino acid was checked by TLC using EtOAc containing a spatula tip of 
ninhydrin as the eluent. The mixture was concentrated at reduced pressure to half the volume, extracted with 
hexane to remove unreacted di-tert-butylcarbonate and the organic phase was washed with satd. aq. 
NaHCO3. The combined aqueous phases were cooled to 0 °C and acidified with 10% aq. KHSO4 to pH = 2, 
extracted with Et2O (16a) or EtOAc (16b-f) and dried (Na2SO4). The removal of the solvents at reduced 
pressure afforded the desired amino acid. Table 1 collects data for the preparation of protected amino acids 
16a-f. 
          


































































N-BOC-Glycine (16a):White crystalline powder, mixture of rotamers, m. p.: 88-90 °C (Lit.1: 87-88 °C). 
FTIR (KBr, cm
-1
): 3500-2400 (OH), 3410 (NH), 1749 (C=O acid + urethane), 1535 (NH). 
1
H NMR of 
rotamer A (minor) (CDCl3, 300 MHz): δ = 1.46 [s, 9H, C(CH3)3], 3.91 (br d, 2H, CH2COOH), 6.83 (br s, 1H, 
NH), 10.24 (br s, 1H, COOH). 
13
C NMR of rotamer A (minor) (CDCl3, 75.5 MHz): δ = 28.28 [C(CH3)3], 
43.40 (NCH3), 81.83 [C(CH3)3], 157.29 (C=O urethane), 174.04 (C=O acid). 
1
H NMR of rotamer B (major) 
(CDCl3, 300 MHz): δ = 1.46 [s, 9H, C(CH3)3], 3.97 (d, 2H, J = 5.3 Hz, CH2COOH), 5.19 (br s, 1H, NH), 
10.24 (br s, 1H, COOH). 
13
C NMR of rotamer B (major) (CDCl3, 75.5 MHz): δ = 28.28 [C(CH3)3], 42.24 








Off-white crystalline powder, mixture of rotamers. m. p.: 88-90 °C. FTIR (KBr, 
cm
-1
): 3500-2400 (OH), 3114 (NH), 1764 (C=O acid), 1751 (C=O urethane). 
1
H NMR of rotamer A (CDCl3, 
300 MHz): δ = 1.44 [s, 9H C(CH3)3], 2.94 (s, 3H, NCH3), 3.95 (s, 2H, CH2COOH). 
13
C NMR of rotamer A 
(CDCl3, 75.5 MHz): δ =  28.26 [C(CH3)3], 35.57 (NCH3), 50.21 (CH2COOH), 80.67 [C(CH3)3], 155.63 
(C=O urethane), 175.03 (C=O acid). 
1
H NMR of rotamer B (CDCl3, 300 MHz): δ = 1.47 [s, 9H C(CH3)3], 
2.95 (s, 3H, NCH3), 4.03 (s, 2H, CH2COOH).
 13
C NMR of rotamer B (CDCl3, 75.5 MHz): δ = 28.32 
[C(CH3)3], 35.64 (NCH3), 50.78 (CH2COOH), 80.67 [C(CH3)3], 156.43 (C=O urethane), 175.14 (C=O acid). 
NMR data were consistent with those of the literature.
2 
N-BOC-GABA (16c): Yellowish viscous resin, mixture of rotamers. FTIR (film, cm-1): 3500-2400 (OH), 
3345 (NH), 1715 (C=O acid + urethane), 1528 (NH). 
1
H NMR (CDCl3, 300 MHz): δ = 1.44 [s, 9H, 
C(CH3)3], 1.82 (m, 2H, CH2CH2CH2), 2.39 (t, 2H, J = 7.3 Hz, CH2COOH), 3.17 (m, 2H, CH2NH), 4.81 
(major) and 6.11 (two br s, 1H, NH), 10.78 (br s, 1H, OH). 
13
C NMR (CDCl3, 75.5 MHz): δ = 25.15 
(CH2CH2CH2), 28.39 [C(CH3)3], 31.35(CH2COOH), 40.21 (major) and 40.96 (CH2NH), 79.47 (major) and 
80.75 [C(CH3)3], 156.26 (major) and 157.76 (C=O urethane),178.26 (C=O acid). NMR data were consistent 
with those of the literature.
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Synthesis of N-Methyl-GABA (15d):  
A mixture of N-methylpyrrolidone (1.00 g, 0.010 mol, 0.97 mL), NaOH (1.62 g, 0.04 mol) and H2O 
(6 mL) was kept at reflux under magnetic stirring for 4 h then added with 12 M HCl up to pH = 1-2. The 
removal of the solvent at reduced pressure gave a solid residue which was treated with hot EtOH  filtered and 
washed with the same solvent to extract the desidered product, the solvent was removed under reduced 
pressure to obtain an oil which was crystallized with acetonitrile to afford N-methyl-GABA hydrochloride as 
a off-white hygroscopic solid ( 0.9214 g, 0.0060 mol, 59 %, Mp. 115-119 °C). A portion of 0.4848 g was 
washed in turn with acetone and diethyl ether achieving 15d as crystalline powder (0.4465 g, 0.0029 mol).  
N-Methyl-GABA (15d): White crystalline powder, m. p.: 122-123 ° C, Lit.4 120-121 °C. FTIR (KBr, cm-1): 
3500-2400 (OH + NH2
+
), 1732 (C=O), 1571 (NH). 
1
H NMR (DMSO-d6, 300 MHz): δ = 1.84 (m, 2H, 
CH2CH2CH2), 2.36 (t, 2H, J = 7.4 Hz, CH2COOH), 2.49 (s, 3H, CH3NH2
+
), 2.86 (t, 2H, J = 7.4 Hz, 
CH2NH2
+









), 174.90 (C=O acid).
 
N-Methyl-GABA hydrochloride was used in the BOC-protection reaction as described above to give N-
methyl-N-BOC-GABA (16d). 
N-methyl-N-BOC-GABA (16d): Yellowish viscous resin. FTIR (film, cm-1): 3500-2400 (OH), 3166 (NH), 
1728 (C=O acid + urethane). 
1
H NMR (CDCl3, 300 MHz): δ = 1.45 [s, 9H, C(CH3)3], 1.84 (m, 2H, 
CH2CH2CH2), 2.36 (t, 2H, J = 7.3 Hz, CH2COOH), 2.85 (s, 3H, CH3N), 3.28 (t, 2H, J = 7.3 Hz, CH2N), 
10.78 (br s, 1H, OH). 
13
C NMR (CDCl3, 75.5 MHz): δ = 22.88 (CH2CH2CH2), 28.41 [C(CH3)3], 31.11 
(CH2COOH), 34.16 (CH3N), 47.94 (CH2N), 79.79 [C(CH3)3], 156.05 (C=O urethane), 178.43 (C=O acid). 





N -diBOC-L-Lysine (16e): Off-white glassy solid, mixture of rotamers. FTIR (KBr, cm-1): 3500-2400 
(OH), 3374 (NH), 1713 (C=O acid + urethane), 1529 (NH). 
1
H NMR (CDCl3, 300 MHz): δ = 1.45 [s, 18H, 
C(CH3)3], 1.30-2.00 (m, 6H, CH2CH2CH2), 3.11 (m, 2H, CH2NH), 4.11-4.38 (m, 1H, CHNH), 4.70 and 6.30 
(two m, 1H, 
ε
NH), 5.27 (d, J = 7.9 Hz, 1H, 
α
NH), 8.50 (broad s, 1H, OH). 
13
C NMR (CDCl3, 75.5 MHz): δ = 
22.42 (CH2), 28.35 [C(CH3)3], 28.42 [C(CH3)3], 29.45 (CH2), 32.10 (CH2), 40.13 (major) and 41.24 
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(CH2NH), 53.24 (major) and 54.58 (CHNH), 79.34 (major) and 80.86 [C(CH3)3], 79.95 (major) and 81.48 
[C(CH3)3], 155.79 (major) and 156.88 (C=O urethane), 156.33 (major) and 158.16 (C=O urethane), 176.27 





N -diBOC-L-Histidine (16f): Off-white solid, mixture of regioisomers, m. p. : 165-168. Lit.7: 165-167 
°C. FTIR (KBr, cm
-1
): 3500-2400 (OH), 3406 (NH), 3141 (CH=), 1762 (C=O acid), 1714 (C=O urethane), 
1497 (NH). 
1
H NMR (CDCl3, 300 MHz): δ = 1.47 [s, 9H, C(CH3)3], 1.60 [s, 9H, C(CH3)3], 3.15-3.34 (m, 2H, 
CH2), 4.49 (m, 1H, CHNH), 5.49 (d, 1H J = 5.8 Hz, NH), 7.21 (s, 1H, CH imidazole), 8.17 (s, 1H, CH 
imidazole). 
13
C NMR (CDCl3, 75.5 MHz): δ =  27.86 [C(CH3)3], 28.39 [C(CH3)3], 29.71 (CH2), 52.77 
(CHNH), 79.74 [C(CH3)3], 86.57 [C(CH3)3], 115.63 (CH imidazole), 136.40 (quaternary C imidazole), 
136.92 (CH imidazole), 146.29 (C=O urethane), 155.21(C=O urethane), 173.02 (C=O acid).  
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Figure S7. Comparison of 
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Figure S8. Comparison of 
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Figure S64. Cytofluorometric analysis of compound 27.
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